HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE NEOPLASMS

Clinical trials for HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE NEOPLASMS trials appear

Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New targeted drug enters human trials for Tough-to-Treat cancers

Disease control Ongoing

This early-stage study is testing a new drug called BT8009 in people with advanced solid tumors that have a specific marker called Nectin-4. The main goals are to find a safe dose, see how the body processes the drug, and get a first look at whether it can shrink tumors. The drug…

Matched conditions: HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE NEOPLASMS

Phase: PHASE1, PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE NEOPLASMS

Get alerted when new HORMONE RECEPTOR POSITIVE, HER2-NEGATIVE NEOPLASMS trials appear

New targeted drug enters human trials for Tough-to-Treat cancers